Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Hosp Infect ; 104(4): 552-559, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31790745

ABSTRACT

BACKGROUND: Healthcare-associated infections (HAIs) in neonatal intensive care units (NICUs) result in increased morbidity, mortality and healthcare costs. HAI rates in Greek NICUs are among the highest in Europe. There is a need to identify the factors that influence the transmission of HAIs and implementation of prevention interventions in this setting. AIM: To understand healthcare workers' perceptions about HAI prevention in Greek NICUs. METHODS: Qualitative interviews were conducted with NICU staff (physicians and nurses) and infection prevention stakeholders (infectious diseases physicians and infection control nurses) working in three hospitals in Athens. Interviews were conducted in Greek, transcribed and translated into English, and analysed using a modified grounded theory approach. FINDINGS: Interviews were conducted with 37 respondents (20 physicians and 17 nurses). Four main barriers to HAI prevention were identified: (1) resource limitations leading to understaffing and cramped space; (2) poor knowledge about HAI prevention; (3) Greek-specific cultural norms, including hierarchy-driven decisions, a reluctance for public workers to do more than they are paid for, a belief that personal experience trumps evidence-based knowledge, and reactive rather than proactive approaches to societal challenges; and (4) lack of a national infection prevention infrastructure. Respondents believed that these barriers could be overcome through organized initiatives, high-quality HAI performance data, interpersonal interactions to build engagement around HAI prevention, and leveraging the hierarchy to promote change from the 'top down'. CONCLUSION: Implementing HAI prevention interventions in Greek NICUs will require consideration of contextual features surrounding the delivery of care, with particular attention paid to national culture.


Subject(s)
Cross Infection/psychology , Health Knowledge, Attitudes, Practice , Health Personnel/psychology , Infection Control , Cross Infection/prevention & control , Greece , Humans , Intensive Care Units, Neonatal , Interviews as Topic
2.
Epidemiol Infect ; 145(7): 1409-1417, 2017 05.
Article in English | MEDLINE | ID: mdl-28219463

ABSTRACT

We conducted a prospective cohort study between 1 January 2010 and 31 December 2012 at five adult and paediatric academic medical centres to identify factors associated with persistent methicillin-resistant Staphylococcus aureus (MRSA) colonisation. Adults and children presenting to ambulatory settings with a MRSA skin and soft tissue infection (i.e. index cases), along with household members, performed self-sampling for MRSA colonisation every 2 weeks for 6 months. Clearance of colonisation was defined as two consecutive negative sampling periods. Subjects without clearance by the end of the study were considered persistently colonised and compared with those who cleared colonisation. Of 243 index cases, 48 (19·8%) had persistent colonisation and 110 (45·3%) cleared colonisation without recurrence. Persistent colonisation was associated with white race (odds ratio (OR), 4·90; 95% confidence interval (CI), 1·38-17·40), prior MRSA infection (OR 3·59; 95% CI 1·05-12·35), colonisation of multiple sites (OR 32·7; 95% CI 6·7-159·3). Conversely, subjects with persistent colonisation were less likely to have been treated with clindamycin (OR 0·28; 95% CI 0·08-0·99). Colonisation at multiple sites is a risk factor for persistent colonisation and may require more targeted decolonisation efforts. The specific effect of clindamycin on MRSA colonisation needs to be elucidated.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/physiology , Staphylococcal Infections/epidemiology , Adolescent , Adult , Aged , Anti-Bacterial Agents/pharmacology , Child , Child, Preschool , Clindamycin/therapeutic use , Female , Humans , Infant , Infant, Newborn , Male , Methicillin/pharmacology , Middle Aged , Pennsylvania/epidemiology , Prevalence , Prospective Studies , Risk Factors , Staphylococcal Infections/microbiology , Young Adult
3.
J Perinatol ; 36(4): 300-5, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26658124

ABSTRACT

OBJECTIVE: To estimate the incidence and identify risk factors for surgical site infections (SSIs) among infants in the neonatal intensive care unit (NICU). STUDY DESIGN: A prospective cohort study of infants undergoing surgical procedures from May 2009 to April 2012 in three NICUs was performed. SSI was identified if documented by an attending neonatologist and treated with intravenous antibiotics. Independent risk factors were identified using logistic regression, adjusting for NICU. RESULT: A total of 902 infants underwent 1346 procedures and experienced 60 SSIs (incidence: 4.46/100 surgeries). Risk factors for SSIs included younger chronological age (odds ratio (OR) 1.03 per day decrease, 95% confidence interval (CI) 1.01, 1.04), lower gestational age (OR 1.09 per week decrease, CI 1.02, 1.18), male sex (OR 1.17, CI 1.04, 1.34) and use of central venous catheter (OR 4.40, CI 1.19, 9.62). Only 43% had surgical site cultures obtained and Staphylococcus aureus was most commonly isolated. CONCLUSION: SSIs complicated 4.46% of procedures performed in the NICU. Although few modifiable risk factors for SSIs were identified, future efforts should focus on evaluating the impact of current prevention strategies on the incidence of neonatal SSI.


Subject(s)
Intensive Care Units, Neonatal , Staphylococcal Infections/epidemiology , Surgical Wound Infection/epidemiology , Anti-Bacterial Agents/therapeutic use , Cefazolin/therapeutic use , Female , Humans , Incidence , Infant, Newborn , Length of Stay , Longitudinal Studies , Male , Prospective Studies , Risk Factors , Staphylococcal Infections/drug therapy , Staphylococcus aureus/isolation & purification , Surgical Wound Infection/drug therapy , Vancomycin/therapeutic use
4.
Epidemiol Infect ; 138(5): 683-5, 2010 May.
Article in English | MEDLINE | ID: mdl-20109256

ABSTRACT

We identified eight consecutive patients who presented with a skin or soft tissue infection due to MRSA. Of seven household members of these cases, three were colonized with MRSA. The mean duration of MRSA colonization in index cases was 33 days (range 14-104), while mean duration of colonization in household cases was 54 days (range 12-95). There was a borderline significant association between having a concurrent colonized household member and a longer duration of colonization (mean 44 days vs. 26 days, P=0.08).


Subject(s)
Carrier State/epidemiology , Family Health , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Outpatients , Soft Tissue Infections/epidemiology , Staphylococcal Skin Infections/epidemiology , Adult , Aged , Carrier State/microbiology , Carrier State/transmission , Family Characteristics , Female , Humans , Male , Middle Aged , Soft Tissue Infections/microbiology , Soft Tissue Infections/transmission , Staphylococcal Skin Infections/microbiology , Staphylococcal Skin Infections/transmission , Time Factors , Young Adult
5.
Clin Microbiol Infect ; 15 Suppl 5: 50-4, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19754758

ABSTRACT

Invasive zygomycosis in neonates and children has both similarities to and differences from that in adults. We searched PubMed and individual references for English-language reports of single cases or case series of neonatal (<1 month) and paediatric (< or =18 years) zygomycosis and compared the results with published results in adults. Cases were included if they fulfilled pre-specified criteria. A total of 59 cases of neonatal zygomycosis were reported to July 2007; 157 paediatric cases were published up to 2004 and an additional 30 paediatric cases were reported more recently. Prematurity was a major underlying factor among neonatal cases. The most common manifestations of zygomycosis were gastrointestinal (54%) and cutaneous (36%). This pattern differs from the sinopulmonary and rhinocerebral patterns typical in older children and adults. Overall mortality was 64% in neonates, 56% in children and 53% in adults. A tendency for dissemination was higher in neonates than adults. Dissemination and young age (<1 year) were independent risk factors for death in children. Most patients who survived received antifungal therapy. Surgery combined with antifungal therapy was a protective factor against death. Most neonates and children who survived had received an amphotericin B formulation. Zygomycosis is a life-threatening infection in children and neonates with differing patterns of involvement in individuals of different ages. The most common management strategy in survivors involved a combination of amphotericin B and surgery.


Subject(s)
Zygomycosis/epidemiology , Zygomycosis/pathology , Adolescent , Age Factors , Antifungal Agents/therapeutic use , Child , Child, Preschool , Debridement , Humans , Infant , Infant, Newborn , Risk Factors , Zygomycosis/mortality , Zygomycosis/therapy
6.
Clin Microbiol Infect ; 15(7): 613-24, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19673972

ABSTRACT

Invasive fungal infections in children appear to have increased over the past few decades. Especially neonates and children with primary and secondary immunodeficiencies are at risk. Candida and Aspergillus spp. are the most commonly isolated organisms. In addition, Malassezia may cause systemic infections in newborns and zygomycosis is important because of its rising incidence and high case fatality rate. Timely diagnosis and initiation of appropriate antifungal therapy is imperative for improving outcomes. However, traditional techniques are time-consuming and representative sample material, using invasive procedures, may be difficult to obtain in the paediatric setting. This review provides an overview of the advances in detection and rapid species identification, with a focus on issues relevant in these settings. Subsequently, the current antifungal treatment options for neonates and children are discussed in light of the antifungal spectrum of the available agents and the specific pharmacokinetic properties in different age groups. Although a multitude of newer antifungal compounds have become available within the last decade, further studies are necessary to clearly establish the role for each of these agents among neonates and children.


Subject(s)
Mycoses , Absidia/classification , Absidia/drug effects , Absidia/isolation & purification , Antifungal Agents/therapeutic use , Aspergillus/classification , Aspergillus/drug effects , Aspergillus/isolation & purification , Candida/classification , Candida/drug effects , Candida/isolation & purification , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Malassezia/classification , Malassezia/drug effects , Malassezia/isolation & purification , Mucor/classification , Mucor/drug effects , Mucor/isolation & purification , Mycoses/diagnosis , Mycoses/drug therapy , Mycoses/microbiology , Mycoses/physiopathology
7.
Lab Anim Sci ; 41(5): 419-22, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1666140

ABSTRACT

Rabbit serum samples from eleven different research facilities were evaluated for the presence of immunoglobulin G against Pasteurella multocida by using an enzyme-linked immunosorbent assay (ELISA). Each facility which submitted serum samples also provided a brief history of each rabbit colony tested. Rabbits from colonies reported to have endemic P. multocida or of undetermined status had 83 (58.9%) of 141 rabbits that were positive. Colonies reported to be free from P. multocida had 110 (92.4%) of 119 rabbits that were negative by ELISA. The ELISA test described here showed a high degree of agreement (92-94%) with two other P. multocida ELISAs at different diagnostic facilities. This study confirms that an ELISA testing for serum antibodies against the P. multocida is a reliable diagnostic tool to screen colonies for P. multocida.


Subject(s)
Antibodies, Bacterial/blood , Enzyme-Linked Immunosorbent Assay/methods , Pasteurella multocida/immunology , Rabbits/microbiology , Animals , Animals, Laboratory/microbiology , Evaluation Studies as Topic , Mass Screening , Pasteurella Infections/diagnosis , Pasteurella Infections/prevention & control
8.
Lab Anim Sci ; 40(4): 402-5, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2166869

ABSTRACT

Few published reports exist describing morbidity and mortality in domestic zebra finch colonies maintained in a laboratory animal setting. A retrospective study of clinical disease and mortality in quarantined adult zebra finches was performed. Animals were observed during the 2 week quarantine period and for at least 1 month afterwards (42 days). Signs of disease, including feather and beak abnormalities, oculonasal discharge, increased respiratory rate or stridor, abdominal enlargement, pasty vent, diarrhea, lameness and pectoral muscle loss, were evaluated in our colony during this time. History, physical examination, laboratory testing and postmortem evaluation were used to determine causes of clinical disease. Common clinical findings in sick finches included sudden death, ruffled feathers, increased respiratory rate or gape mouthed breathing, pasty vent or frank diarrhea, and beak discoloration. Organisms frequently isolated were Staphylococcus spp., E. coli, Enterobacter spp., and Coccidia spp. Of the finches that died while in the colony (29.5%), 23.0% died in the first week after arrival. Pathogens frequently isolated from tissues cultured at necropsy included: E. coli, Staphylococcus aureus, Enterobacter spp., and Candida albicans. When observed, pathological lesions consisted of air sacculitis, fibrinopurulent polyserositis and ventriculitis.


Subject(s)
Bird Diseases/epidemiology , Candidiasis/veterinary , Staphylococcal Infections/veterinary , Animals , Bird Diseases/mortality , Birds , Candidiasis/epidemiology , Candidiasis/mortality , Female , Male , Retrospective Studies , Staphylococcal Infections/epidemiology , Staphylococcal Infections/mortality , Staphylococcus aureus/isolation & purification , Staphylococcus epidermidis/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...